369 related articles for article (PubMed ID: 22359151)
1. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.
Colosimo C; Tiple D; Berardelli A
Neurotox Res; 2012 Nov; 22(4):265-73. PubMed ID: 22359151
[TBL] [Abstract][Full Text] [Related]
2. Craniocervical dystonia: clinical and pathophysiological features.
Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxins in the treatment of primary focal dystonias.
Truong D
J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
Del Sorbo F; Albanese A
Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and long-term efficacy of botulinum toxin type B in the treatment of cervical dystonia: report of 4 prospective, multicenter trials.
Chinnapongse RB; Lew MF; Ferreira JJ; Gullo KL; Nemeth PR; Zhang Y
Clin Neuropharmacol; 2012; 35(5):215-23. PubMed ID: 22932474
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more.
Lungu C; Karp BI; Alter K; Zolbrod R; Hallett M
Mov Disord; 2011 Mar; 26(4):750-3. PubMed ID: 21506157
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin therapy for cervical dystonia.
Walker FO
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
Hassell TJW; Charles D
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32331272
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up.
Petracca M; Lo Monaco MR; Ialongo T; Di Stasio E; Cerbarano ML; Maggi L; De Biase A; Di Lazzaro G; Calabresi P; Bentivoglio AR
J Neurol; 2023 Jan; 270(1):340-347. PubMed ID: 36068376
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin treatment of occupational and focal hand dystonia.
Karp BI
Mov Disord; 2004 Mar; 19 Suppl 8():S116-9. PubMed ID: 15027063
[TBL] [Abstract][Full Text] [Related]
13. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP
Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979
[TBL] [Abstract][Full Text] [Related]
14. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
Dutton JJ
Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
[TBL] [Abstract][Full Text] [Related]
15. [Focal or Segmental Dystonia Resistant to Botulinum Toxin: How Do You Treat Patients in Whom Botulinum Toxin Treatment Has No Effect?].
Nomura T
Brain Nerve; 2022 May; 74(5):581-587. PubMed ID: 35589651
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?
Jinnah HA; Comella CL; Perlmutter J; Lungu C; Hallett M;
Toxicon; 2018 Jun; 147():89-95. PubMed ID: 28888929
[TBL] [Abstract][Full Text] [Related]
17. The treatment of cervical dystonia with botulinum toxins.
Comella CL
J Neural Transm (Vienna); 2008; 115(4):579-83. PubMed ID: 17994181
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
19. Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.
Nijmeijer SW; Koelman JH; Kamphuis DJ; Tijssen MA
Parkinsonism Relat Disord; 2012 Jul; 18(6):731-6. PubMed ID: 22575237
[TBL] [Abstract][Full Text] [Related]
20. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
Marion MH; Humberstone M; Grunewald R; Wimalaratna S
Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
